Moleculin Biotech Inc.
Organization details
- Legal name
- Moleculin Biotech Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Houston
- Headquarters state / province
- Texas
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- MBRX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001659617
- EIN
- 47-4671997
Board of directors
-
Elizabeth Cermak · DirectorSince 2023
-
John M. Climaco · DirectorSince 2023
-
Joy Yan · DirectorSince 2023
-
Michael D. Cannon · DirectorSince 2023
-
Robert E. George · DirectorSince 2023
-
Walter Klemp V · Director · CEO and PresidentSince 2023
Chief executives
Director election results
Annual meeting of October 9, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
78.0%
-
79.0%
-
79.1%
-
80.1%
-
80.2%
Board connections
2 of this board's directors also sit on 2 other boards. 2 are in the same sector.
-
Autonomix Medical Inc. Same sectorvia Walter Klemp V
-
CNS Pharmaceuticals Inc. Same sectorvia John M. Climaco
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 3 purchases by 3 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 4, 2026 | Jonathan P. Foster Officer (Chief Financial Officer) | Option exercise | +41 | — | — |
| Nov 4, 2026 | Walter Klemp V Director, Officer (CEO and President) | Option exercise | +57 | — | — |
| Nov 4, 2026 | PICKER DONALD H Officer (Chief Science Officer) | Option exercise | +17 | — | — |
| Nov 4, 2026 | Jonathan P. Foster Officer (Chief Financial Officer) | Shares withheld for tax | −10 | $8.46 | $85 |
| Nov 4, 2026 | Walter Klemp V Director, Officer (CEO and President) | Shares withheld for tax | −14 | $8.46 | $118 |
| Nov 4, 2026 | PICKER DONALD H Officer (Chief Science Officer) | Shares withheld for tax | −4 | $8.46 | $34 |
| Oct 15, 2026 | Jonathan P. Foster Officer (Chief Financial Officer) | Option exercise | +130,000 | — | — |
| Oct 15, 2026 | Walter Klemp V Director, Officer (CEO and President) | Option exercise | +207,500 | — | — |
| Oct 15, 2026 | Jonathan P. Foster Officer (Chief Financial Officer) | Shares withheld for tax | −30,485 | $0.37 | $11,283 |
| Oct 15, 2026 | Walter Klemp V Director, Officer (CEO and President) | Shares withheld for tax | −48,659 | $0.37 | $18,009 |
| Aug 3, 2026 | Jonathan P. Foster Officer (Chief Financial Officer) | Open-market purchase | +293,333 | — | — |
| Aug 3, 2026 | Walter Klemp V Director, Officer (CEO and President) | Open-market purchase | +533,333 | — | — |
| Aug 3, 2026 | PICKER DONALD H Officer (Chief Science Officer) | Open-market purchase | +173,333 | — | — |
| Jun 22, 2026 | PICKER DONALD H Officer (Chief Science Officer) | Option exercise | +71 | — | — |
| Jun 22, 2026 | Walter Klemp V Director, Officer (CEO and President) | Option exercise | +360 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Moleculin Biotech Inc.
Who is the CEO of Moleculin Biotech Inc.?
Walter Klemp V is Moleculin Biotech Inc.'s CEO and President.
How many directors are on Moleculin Biotech Inc.'s board?
Moleculin Biotech Inc.'s board has 6 directors: Elizabeth Cermak, John M. Climaco, Joy Yan, Michael D. Cannon, Robert E. George and Walter Klemp V.
Are Moleculin Biotech Inc. insiders buying or selling shares?
Over the last 12 months, Moleculin Biotech Inc. insiders bought $0 of shares in 3 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="moleculin-biotech-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.